Influence of anthroposophical supportive medicine on treatment-related toxicity in children receiving cancer therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN64676790

Enrollment

340

Registered

2006-06-30

Start date

2005-11-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumours, lymphoma and leukaemia Cancer Leukaemia of unspecified cell type

Interventions

We plan to include 340 children with malignancies to be randomly allocated to an arm with anthroposophically-supported medicine in addition to standard treatment compared to an arm with standard treat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The trial will be open to patients being treated according to current protocols for solid tumours, lymphoma and leukaemia in the German Society for Paediatric Oncology and Haematology (GPOH), aged between 1 and 18 years

Exclusion criteria

Exclusion criteria: Current use of any experimental therapy

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Quality of life questionnaires	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026